Buy CytRx Stock | CYTR Stock Price & Latest News | Public
CYTR

CytRx

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About CYTR

    CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discove...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    -0.05
    -0.06
    -0.08
    -0.09
    Q4 2019

    Expected EPS
    Q4 2019

    -$0.05

    Actual EPS
    Q4 2019

    -$0.09

    Stats

    Market Cap$26,81M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.85
    1 Year Low$0.23
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app